Preserving Visual Function in the Aging Population
Jointly provided by the New England College of Optometry and PlatformQ Health Education, LLC
New England College of Optometry designates this activity for a maximum of 2 hours/units of COPE-Accredited CE. After watching the webinar/video at http://www.clinicalserieslive.com/, candidates must complete the online post-course test for each course to verify learning and qualify for up to 2 hours/units of COPE-Accredited CE. Printable certificates of completion are generated for participants who successfully pass the post-course test for each course with a score of 70% or higher. The instructional time for each course is a minimum of 50 minutes.
This activity has been planned and implemented through the joint sponsorship of New England College of Optometry and PlatformQ Health Education, LLC. New England College of Optometry is accredited by The Council on Optometric Practitioner Education® (COPE®), created by the Association of Regulatory Boards of Optometry (ARBO) to accredit continuing education on behalf of optometric licensing boards.
Interactive Online Courses
New England College of Optometry designates each interactive online course for a maximum of 1 hour/unit of COPE-Accredited CE.
Enduring Online Courses
New England College of Optometry designates each enduring online course for a maximum of 1 hour/unit of COPE-Accredited continuing education.
DATE OF RELEASE/EXPIRATION
Webinar – Interactive Online Courses
Session I – Differentiating Causes of Decreased Visual Acuity: The Optometrist on the Front Lines of Care
Thursday, July 10, 2017 from 11:00 AM – 12:00 PM ET
Session II – ‘I Didn’t See This Coming!’ Optometric Case Studies in Visual Acuity Challenges
Thursday, August 10, 2017 from 12:00–1:00 PM ET
Video – Enduring Online Courses
Both sessions expire August 10, 2018
At the conclusion of this activity, participants will be able to:
|•||Describe measures that indicate that a patient has reduced visual acuity|
|•||Identify patient barriers to annual eye examinations and how such barriers may be effectively addressed to management of patients who experience reduction in visual acuity|
|•||Discuss the evolving role of the optometrist as part of the eye and health care team that can optimize eye health and visual outcomes for patients with conditions that affect visual acuity|
|•||Discuss the management of challenging patient scenarios that share reduced visual acuity as a symptom|
This activity is intended for US-based optometrists who have significant numbers of older patients with decreased visual acuity in their patient care panels.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
This activity is supported by an unrestricted educational grant from Genentech, Inc. The content and format of this course was planned and prepared independently without the input from members of a commercial interest.
METHOD OF PARTICIPATION
There are no fees to participate in this activity. To participate in the activity, go to http://www.clinicalserieslive.com/. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. Participants must receive a minimum score of 70% on the posttest in order to receive a certificate of completion.
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
STATEMENT OF DISCLOSURE AND INDEPENDENCE
New England College of Optometry (NECO) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to NECO policy. NECO is committed to providing its learners with high quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
|Name of Faculty or Presenter||Commercial Interest||Reported Financial Relationship|
|Dean Eliott, MD
||Bausch + Lomb
Santen Pharmaceutical Co., Ltd.
|Mark T. Dunbar, OD, FAAO||Genentech, Inc.
Regeneron Pharmaceuticals, Inc.
Carl Zeiss Meditech, Inc.
Advisory Board Member
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
|Name of Planner||Reported Financial Relationship|
|Camille Ruán, NECO Planner||None|
|Tony Cavallerano, OD; NECO Manager||None|
|Elizabeth del Nido, PlatformQ Health Education, LLC Planner||None|
DISCLOSURE OF UNAPPROVED/OFF LABEL USE (if applicable):
This work may discuss off-label uses of medications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and professional development. The information presented in this activity is not meant to serve as a guideline for patient care. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, applicable manufacturers’ product information, and comparison with recommendations of other authorities.
Please contact New England College of Optometry at http://www.neco.edu/.
For any technical issues or issues with your CE Certificate, please contact ClinicalSeriesLive at 877-394-1306 or at http://www.clinicalserieslive.com/.